5-Hydroxytryptamine-3 Antagonists: A New Class of Potent Antiemetics in Cancer Therapy

1991; Springer Science+Business Media; Linguagem: Inglês

10.1007/978-3-642-84138-5_10

ISSN

2197-6767

Autores

M. Soukop,

Tópico(s)

Pharmacological Effects and Toxicity Studies

Resumo

For many years nausea and vomiting have been recognized as side-effects of numerous chemotherapeutic regimens. The development of the useful new agent cisplatin, due with its powerful emetic effect, highlighted this patient problem.

Referência(s)